These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16278356)

  • 21. [Fluoxetine and convulsive crisis].
    Montero Pérez FJ
    Med Clin (Barc); 2000 May; 114(20):790-1. PubMed ID: 10923328
    [No Abstract]   [Full Text] [Related]  

  • 22. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.
    Oberlander TF; Bonaguro RJ; Misri S; Papsdorf M; Ross CJ; Simpson EM
    Mol Psychiatry; 2008 Jan; 13(1):65-73. PubMed ID: 17519929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal encephalopathy after antidepressant exposure during pregnancy. Herbst F, Gortner L. Paroxetine withdrawal syndrome as differential diagnosis of acute neonatal encephalophathy? Z Geburtsh Neonatol 2003; 207: 232-234.
    Jessel N; Stiskal JA
    Z Geburtshilfe Neonatol; 2004 Apr; 208(2):75-6; author reply 76. PubMed ID: 15112141
    [No Abstract]   [Full Text] [Related]  

  • 24. Sculpting infant soothability: the role of prenatal SSRI antidepressant exposure and neonatal SLC6A4 methylation status.
    Gartstein MA; Hookenson KV; Brain U; Devlin AM; Grunau RE; Oberlander TF
    Dev Psychobiol; 2016 Sep; 58(6):745-58. PubMed ID: 27254389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy.
    Bot P; Semmekrot BA; van der Stappen J
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F153. PubMed ID: 16492956
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective serotonin reuptake inhibitor syndrome: precipitated by concomitant clozapine?
    Lu ML; Lane HY; Chang WH
    J Clin Psychopharmacol; 1999 Aug; 19(4):386-7. PubMed ID: 10440475
    [No Abstract]   [Full Text] [Related]  

  • 27. Serotonin syndrome in a breast-fed neonate.
    Morris R; Matthes J
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25948853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review.
    Bellantuono C; Migliarese G; Gentile S
    Hum Psychopharmacol; 2007 Apr; 22(3):121-8. PubMed ID: 17397101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Post-parathyroidectomy paresthesiae due to fluoxetin withdrawal].
    Alvarez-Miezentseva V; Sitges-Serra A
    Med Clin (Barc); 2006 Jun; 127(4):159. PubMed ID: 16831403
    [No Abstract]   [Full Text] [Related]  

  • 30. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dispensing error resulting in possible fluoxetine overdose and subsequent discontinuation syndrome in a child.
    Velez LI; Feng SY; Neerman MF
    Clin Pediatr (Phila); 2010 Nov; 49(11):1072-4. PubMed ID: 20522613
    [No Abstract]   [Full Text] [Related]  

  • 32. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.
    Nordeng H; Lindemann R; Perminov KV; Reikvam A
    Acta Paediatr; 2001 Mar; 90(3):288-91. PubMed ID: 11332169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
    Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study.
    Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
    Br J Psychiatry; 2008 May; 192(5):338-43. PubMed ID: 18450656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoxetine during pregnancy: impact on fetal development.
    Morrison JL; Riggs KW; Rurak DW
    Reprod Fertil Dev; 2005; 17(6):641-50. PubMed ID: 16263070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional implications of observed neurobehavioral disturbances and reduced gestation length in infants of mothers using selective serotonin reuptake inhibitors during pregnancy.
    Vavasour E
    Pediatrics; 2004 Jul; 114(1):325. PubMed ID: 15231956
    [No Abstract]   [Full Text] [Related]  

  • 37. Birth outcomes after prenatal exposure to antidepressant medication.
    Hendrick V; Smith LM; Suri R; Hwang S; Haynes D; Altshuler L
    Am J Obstet Gynecol; 2003 Mar; 188(3):812-5. PubMed ID: 12634662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac arrhythmia in a newborn infant associated with fluoxetine use during pregnancy.
    Abebe-Campino G; Offer D; Stahl B; Merlob P
    Ann Pharmacother; 2002 Mar; 36(3):533-4. PubMed ID: 11895072
    [No Abstract]   [Full Text] [Related]  

  • 39. Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram.
    Potts AL; Young KL; Carter BS; Shenai JP
    J Perinatol; 2007 Feb; 27(2):120-2. PubMed ID: 17262045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.